FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2636128416> ?p ?o ?g. }

• W2636128416 endingPage "123" @default.
• W2636128416 startingPage "113" @default.
• W2636128416 abstract "Diabetes Mellitus (DM) is a multidimensional, multisystemic, metabolic disorder arises due to the deficiency (Type 1) or efficiency (Type 2) of insulin, a hormone synthesized by the pancreatic β cells. DM is recognized by persistent elevation in fasting as well as post prandial blood glucose levels. Though, drugs are plenty for the treatment of diabetes, none is found to be an ideal due to undesirable side effects and diminution associated with prolonged treatment. Further, excessive generations of free radicals have also been implicated in the onset and progression of diabetes and its secondary complications. Hence, search for novel drugs without side effects preferably from the plant origin continues. In the present study, an attempt has been made to scientifically evaluate the antidiabetic properties of GTF – 231, an ayurvedic formulation in high fat diet-low dose streptozotocin induced experimental type 2 diabetes in rats. GTF 231 contains plant secondary metabolites such as Gymnemic acid, Trigonelline and Ferulic acid in the ratio of 2: 3: 1. Oral glucose tolerance test (OGTT) was performed to study the effect of the GTF-231on glucose homeostasis. Insulin tolerance test (ITT) was performed to evaluate the effect of GTF-231 on insulin sensitivity. Insulin resistance was also measured by HOMA-IR.Oral administration of GTF- 231(300mg/kg.b.w./rat/day) for a period of 30 days significantly improved the glucose homeostasis in diabetic rats which is evidenced from the results of OGTT, ITT and HOMA-IR. Further, the treatment significantly improved the altered levels of fasting blood glucose, glycosylated hemoglobin (HbA1c), protein, urea, uric acid and creatinine. The altered activities of liver enzyme markers such as AST, ALT and ALP observed in the diabetic rats were reverted back to near normal after treatment with GTF- 231. The altered activities of carbohydrate metabolizing enzymes such as glucokinase, pyruvate kinase, glucose-6-phosphatase, fructose-1,6-bisphosphatase, glucose-6- phosphate dehydrogenase, lactate dehydrogenase in hepatic tissues of diabetic rats were significantly reverted to near normalcy upon treatment with GTF-231.The efficacy of the drug was comparable with metformin, a standard drug widely used for the treatment of diabetes. In conclusion, the data obtained clearly established that the ayurvedic formulation has significant antidiabetic activity which in turn may be due to the synergetic effect of the individual phytochemicals present in the formulation." @default.
• W2636128416 created "2017-06-30" @default.
• W2636128416 creator A5023963195 @default.
• W2636128416 creator A5037324455 @default.
• W2636128416 creator A5038559713 @default.
• W2636128416 date "2015-01-01" @default.
• W2636128416 modified "2023-09-22" @default.
• W2636128416 title "Antidiabetic properties of GTF â 231, an ayurvedic formulation studied inhigh fat diet fed-low dose STZ induced experimental type 2 diabetes in rats" @default.
• W2636128416 hasPublicationYear "2015" @default.
• W2636128416 type Work @default.
• W2636128416 sameAs 2636128416 @default.
• W2636128416 citedByCount "0" @default.
• W2636128416 crossrefType "journal-article" @default.
• W2636128416 hasAuthorship W2636128416A5023963195 @default.
• W2636128416 hasAuthorship W2636128416A5037324455 @default.
• W2636128416 hasAuthorship W2636128416A5038559713 @default.
• W2636128416 hasConcept C126322002 @default.
• W2636128416 hasConcept C134018914 @default.
• W2636128416 hasConcept C2777180221 @default.
• W2636128416 hasConcept C2777391703 @default.
• W2636128416 hasConcept C2779280383 @default.
• W2636128416 hasConcept C2779306644 @default.
• W2636128416 hasConcept C2780833929 @default.
• W2636128416 hasConcept C3018667095 @default.
• W2636128416 hasConcept C555293320 @default.
• W2636128416 hasConcept C71924100 @default.
• W2636128416 hasConceptScore W2636128416C126322002 @default.
• W2636128416 hasConceptScore W2636128416C134018914 @default.
• W2636128416 hasConceptScore W2636128416C2777180221 @default.
• W2636128416 hasConceptScore W2636128416C2777391703 @default.
• W2636128416 hasConceptScore W2636128416C2779280383 @default.
• W2636128416 hasConceptScore W2636128416C2779306644 @default.
• W2636128416 hasConceptScore W2636128416C2780833929 @default.
• W2636128416 hasConceptScore W2636128416C3018667095 @default.
• W2636128416 hasConceptScore W2636128416C555293320 @default.
• W2636128416 hasConceptScore W2636128416C71924100 @default.
• W2636128416 hasIssue "7" @default.
• W2636128416 hasLocation W26361284161 @default.
• W2636128416 hasOpenAccess W2636128416 @default.
• W2636128416 hasPrimaryLocation W26361284161 @default.
• W2636128416 hasRelatedWork W1985878450 @default.
• W2636128416 hasRelatedWork W1993308231 @default.
• W2636128416 hasRelatedWork W1994650650 @default.
• W2636128416 hasRelatedWork W2003930709 @default.
• W2636128416 hasRelatedWork W2017058203 @default.
• W2636128416 hasRelatedWork W2019900313 @default.
• W2636128416 hasRelatedWork W2064482859 @default.
• W2636128416 hasRelatedWork W2188015958 @default.
• W2636128416 hasRelatedWork W2288235747 @default.
• W2636128416 hasRelatedWork W2315371304 @default.
• W2636128416 hasRelatedWork W2624231378 @default.
• W2636128416 hasRelatedWork W2772753823 @default.
• W2636128416 hasRelatedWork W2894575271 @default.
• W2636128416 hasRelatedWork W2922746971 @default.
• W2636128416 hasRelatedWork W3010125055 @default.
• W2636128416 hasRelatedWork W3018851011 @default.
• W2636128416 hasRelatedWork W3161322921 @default.
• W2636128416 hasRelatedWork W3183614828 @default.
• W2636128416 hasRelatedWork W3195162985 @default.
• W2636128416 hasRelatedWork W3211006267 @default.
• W2636128416 hasVolume "7" @default.
• W2636128416 isParatext "false" @default.
• W2636128416 isRetracted "false" @default.
• W2636128416 magId "2636128416" @default.
• W2636128416 workType "article" @default.